Sugi Predict

Sugi Predict / Compounds / SCHEMBL765407

SCHEMBL765407

SCHEMBL765407

Nc1nc2c(s1)CN(C(=O)O)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD52 P43351 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ APOBEC3A P31941 1/20 0.39
▸ APOBEC3G Q9HC16 1/20 0.39
▸ MAPT P10636 4/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ GRM5 P41594 3/20 0.33
▸ SCN9A Q15858 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28449516 0.85 DRD2 (0.43) RAD52RECQLAPOBEC3AAPOBEC3GMAPT
SCHEMBL175426 0.85 RAD52 (0.53) RAD52RECQLAPOBEC3AAPOBEC3GMAPT
SCHEMBL1503764 0.80 GRM5 (0.33) GRM5NPC1RAB9A
SCHEMBL5257381 0.78 ALDH1A1 (0.47) MAPTALDH1A1MAPK1KDM4EHSD17B10
SCHEMBL741852 0.77 ADORA1 (0.47) RAD52RECQLMAPTKDM4ESCN3A
SCHEMBL5908794 0.73 GRM5 (0.55) RAD52RECQLAPOBEC3AAPOBEC3GMAPT
SCHEMBL20305159 0.72 NPC1 (0.61) LMNAHRH3GRM5NPC1RAB9A
SCHEMBL10825454 0.70 RAD52 (0.51) RAD52RECQLAPOBEC3AAPOBEC3GMAPT
SCHEMBL17933982 0.70 RAD52 (0.51) RAD52RECQLAPOBEC3AAPOBEC3GMAPT
SCHEMBL15240212 0.70 RAD52 (0.48) RAD52RECQLAPOBEC3AAPOBEC3GMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105837599-A N-substituted-3,5-disubstituted benzamide compound, preparation method and application thereof 中国科学院上海药物研究所 2016-08-10 — — CN disclosed
EP-1405852-B9 DIAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2013-03-27 — — EP disclosed
EP-1405852-B1 DIAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2012-08-01 — — EP disclosed
EP-1270557-B1 ETHYLENEDIAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2012-07-25 — — EP disclosed
EP-2431370-A1 Monoacylated 1,2-diaminocycloalkanes DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2012-03-21 — — EP disclosed
US-20110312990-A1 Diamine Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-22 — — US disclosed
EP-2343290-A1 Diamine derivatives as factor X inhibitors Daiichi Sankyo Company, Limited (JP) 2011-07-13 — — EP disclosed
US-20110077266-A1 Diamine Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-03-31 — — US disclosed
US-20100093785-A1 DIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2010-04-15 — — US disclosed
US-20090270446-A1 DIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-10-29 — — US disclosed
US-7365205-B2 Cyclic diamine derivatives useful as agents for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism; inhibit activated blood coagulation factor X DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-04-29 — — US disclosed
US-7342014-B2 Diamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-03-11 — — US disclosed
US-20080015215-A1 DIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-01-17 — — US disclosed
US-20050245565-A1 Diamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-11-03 — — US disclosed
US-20050119486-A1 Diamine derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2005-06-02 — — US disclosed
US-20050020645-A1 Diamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-01-27 — — US disclosed
EP-1415992-A1 DIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 — — EP disclosed
EP-1405852-A1 DIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-04-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270446-A1 DIAMINE DERIVATIVES F2, TFPI, F3 RAD52 1581/4885RECQL 1712/4885APOBEC3A 310/4885
US-20050020645-A1 Diamine derivatives C9, C1S, C1R RAD52 1613/4885RECQL 23/4885APOBEC3A 3403/4885
US-20080015215-A1 DIAMINE DERIVATIVES C9, C1S, C1R RAD52 1613/4885RECQL 23/4885APOBEC3A 3403/4885
US-20050245565-A1 Diamine derivatives C9, C1S, C1R RAD52 1613/4885RECQL 23/4885APOBEC3A 3403/4885
US-20100093785-A1 DIAMINE DERIVATIVES C9, C1S, C1R RAD52 1670/4885RECQL 26/4885APOBEC3A 3520/4885
US-20050119486-A1 Diamine derivatives C9, C1S, C1R RAD52 1613/4885RECQL 23/4885APOBEC3A 3403/4885
US-20110077266-A1 Diamine Derivatives F2, TFPI, F3 RAD52 1581/4885RECQL 1712/4885APOBEC3A 310/4885
US-20110312990-A1 Diamine Derivatives C9, C1S, C1R RAD52 1611/4885RECQL 31/4885APOBEC3A 3831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.